Fang Ni
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Fang Ni has a total of 85 co-authors. Here are the top co-authors by number of shared publications:
Tingting Liang
State Key Laboratory of Immune Response and Immunotherapy, Department of Hematology, The First Affiliated Hospital of USTC, Institute of Blood and Cell Therapy and Anhui Provincial Key Laboratory of Blood Research and Applications, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China
9 shared publicationsMingming Zhu
State Key Laboratory of Immune Response and Immunotherapy, Department of Hematology, The First Affiliated Hospital of USTC, Institute of Blood and Cell Therapy and Anhui Provincial Key Laboratory of Blood Research and Applications, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China
7 shared publicationsXian Song
State Key Laboratory of Immune Response and Immunotherapy, Department of Hematology, The First Affiliated Hospital of USTC, Institute of Blood and Cell Therapy and Anhui Provincial Key Laboratory of Blood Research and Applications, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China
7 shared publicationsMingming Wu
Department of Hematology, The First Affiliated Hospital of USTC, National Key Laboratory of Immune Response and Immunotherapy, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China
6 shared publicationsRui Zhao
State Key Laboratory of Immune Response and Immunotherapy, Department of Hematology, The First Affiliated Hospital of USTC, Institute of Blood and Cell Therapy and Anhui Provincial Key Laboratory of Blood Research and Applications, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China
6 shared publicationsXinru Liu
6 shared publications
Latest Publications
- 11 November 2026
- Published by Springer Nature in Nature Aging
A retinol–SREBP1–ELOVL6 lipogenic axis remodels NK cell biomechanics and constrains immune surveillance during aging
Aging is associated with a progressive decline in immune surveillance, yet the mechanisms that constrain this process remain incompletely understood. Here we uncover a lipid-biomechanical mechanism in human natural killer (NK) cells that contributes to age-related immune decline. We show that aging drives a coordinated metabolic and physical state in NK cells, marked by lipid accumulation, increased membrane fluidity, reduced cortical stiffness and defective immune synapse organization, ultimately impairing target cell killing. Mechanistically, aging induces a retinoid-dependent metabolic shift in NK cells, characterized by enhanced retinol uptake and intracellular retinoic acid accumulation, which activates an SREBP1-dependent lipogenic program with ELOVL6 as a key downstream effector. This program remodels fatty-acyl composition, alters membrane and cortical mechanics, and constrains NK cell cytotoxic function. ELOVL6 inhibition restores membrane and cortical mechanics, rescues cytotoxicity in vitro and enhances antitumor activity in mouse models. These findings establish a targetable biomechanical mechanism linking aging to impaired immune surveillance.
- 11 November 2026
- Published by Springer Nature in Nature Aging
A retinol–SREBP1–ELOVL6 lipogenic axis remodels NK cell biomechanics and constrains immune surveillance during aging
Aging is associated with a progressive decline in immune surveillance, yet the mechanisms that constrain this process remain incompletely understood. Here we uncover a lipid-biomechanical mechanism in human natural killer (NK) cells that contributes to age-related immune decline. We show that aging drives a coordinated metabolic and physical state in NK cells, marked by lipid accumulation, increased membrane fluidity, reduced cortical stiffness and defective immune synapse organization, ultimately impairing target cell killing. Mechanistically, aging induces a retinoid-dependent metabolic shift in NK cells, characterized by enhanced retinol uptake and intracellular retinoic acid accumulation, which activates an SREBP1-dependent lipogenic program with ELOVL6 as a key downstream effector. This program remodels fatty-acyl composition, alters membrane and cortical mechanics, and constrains NK cell cytotoxic function. ELOVL6 inhibition restores membrane and cortical mechanics, rescues cytotoxicity in vitro and enhances antitumor activity in mouse models. These findings establish a targetable biomechanical mechanism linking aging to impaired immune surveillance.
- Open Access
- 27 July 2026
- Published by Elsevier in Cell Reports
- Vol. 45 (8)
GBP6 maintains mitochondrial bioenergetics to promote immune evasion from NK cells in cervical cancer
- 27 July 2026
- Published by Elsevier in Cell Reports
- Vol. 45 (8)
Open AccessGBP6 maintains mitochondrial bioenergetics to promote immune evasion from NK cells in cervical cancer
- Open Access
- 11 March 2026
- Published by Elsevier in Cell Reports
- Vol. 45 (3) , 117072
Single-cell transcriptional and epigenomic landscape of human blood immune cells across the lifespan
- 11 March 2026
- Published by Elsevier in Cell Reports
- Vol. 45 (3) , 117072
Open AccessSingle-cell transcriptional and epigenomic landscape of human blood immune cells across the lifespan
- Open Access
- 6 December 2025
- Published by Wiley in Aging Cell
- Vol. 25 (1) , e70316
A Global Metabolomic and Lipidomic Landscape of Human Plasma Across the Lifespan
Understanding metabolic changes across the human lifespan is essential for addressing age‐related health challenges. However, comprehensive metabolomic and lipidomic analyses, particularly in human plasma, remain underexplored. Herein, we performed untargeted metabolomics and lipidomics profiling of plasma collected from 136 individuals aged 0–84 years. This analysis reveals distinct metabolic signatures across life stages, with newborns displaying unique sphingosine (SPH) profiles, while aging was found to be characterized by elevated amino acid levels and lipid imbalances. Notably, we identified linear and nonlinear metabolic trajectories across the lifespan, highlighting critical transition points reflecting the key stages of metabolic reprogramming. By integrating these metabolic patterns, we developed an “aging clock” based on plasma metabolite profiling, thus providing a powerful tool to predict biological age. These findings offer new insights into the dynamic metabolic landscape of aging, paving the way for targeted interventions to improve healthspan and prevent age‐related diseases.
- 6 December 2025
- Published by Wiley in Aging Cell
- Vol. 25 (1) , e70316
Open AccessA Global Metabolomic and Lipidomic Landscape of Human Plasma Across the Lifespan
Understanding metabolic changes across the human lifespan is essential for addressing age‐related health challenges. However, comprehensive metabolomic and lipidomic analyses, particularly in human plasma, remain underexplored. Herein, we performed untargeted metabolomics and lipidomics profiling of plasma collected from 136 individuals aged 0–84 years. This analysis reveals distinct metabolic signatures across life stages, with newborns displaying unique sphingosine (SPH) profiles, while aging was found to be characterized by elevated amino acid levels and lipid imbalances. Notably, we identified linear and nonlinear metabolic trajectories across the lifespan, highlighting critical transition points reflecting the key stages of metabolic reprogramming. By integrating these metabolic patterns, we developed an “aging clock” based on plasma metabolite profiling, thus providing a powerful tool to predict biological age. These findings offer new insights into the dynamic metabolic landscape of aging, paving the way for targeted interventions to improve healthspan and prevent age‐related diseases.
- Open Access
- 1 December 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 10800
Targeting leukemic stem cell biomechanics suppresses stemness and enhances NK cell-mediated immunotherapy
Acute myeloid leukemia (AML) is primarily driven by leukemic stem cells (LSCs), the main cause of relapse and therapy resistance. Here, we discover that LSCs are predominantly small and mechanically soft. These mechanical properties enable their selective isolation using microfluidic chips. Single-cell RNA-sequencing of primary human AML bone marrow identifies enrichment of LSCs within the FSClow ALDH1A1+ subpopulation, which exhibits long-term stemness in functional assays. Notably, inhibiting ALDH1A1 in these cells promotes F-actin polymerization and increases cellular stiffness, reducing their stemness while enhancing their susceptibility to natural killer (NK) cell-mediated cytotoxicity. In AML patient-derived xenograft models, the combination of ALDH1A1 inhibition with NK cell therapy markedly suppresses leukemia progression. These findings suggest that targeting the mechanical properties of LSC offers a promising strategy to overcome AML treatment resistance, providing insights into stem cell mechanobiology and paving the way for combining targeted therapies with immunotherapy to improve clinical outcomes.
- 1 December 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 10800
Open AccessTargeting leukemic stem cell biomechanics suppresses stemness and enhances NK cell-mediated immunotherapy
Acute myeloid leukemia (AML) is primarily driven by leukemic stem cells (LSCs), the main cause of relapse and therapy resistance. Here, we discover that LSCs are predominantly small and mechanically soft. These mechanical properties enable their selective isolation using microfluidic chips. Single-cell RNA-sequencing of primary human AML bone marrow identifies enrichment of LSCs within the FSClow ALDH1A1+ subpopulation, which exhibits long-term stemness in functional assays. Notably, inhibiting ALDH1A1 in these cells promotes F-actin polymerization and increases cellular stiffness, reducing their stemness while enhancing their susceptibility to natural killer (NK) cell-mediated cytotoxicity. In AML patient-derived xenograft models, the combination of ALDH1A1 inhibition with NK cell therapy markedly suppresses leukemia progression. These findings suggest that targeting the mechanical properties of LSC offers a promising strategy to overcome AML treatment resistance, providing insights into stem cell mechanobiology and paving the way for combining targeted therapies with immunotherapy to improve clinical outcomes.
- 12 April 2025
- Published by Elsevier in International Immunopharmacology
- Vol. 154, 114566
Dysregulated glutathione metabolism impairs natural killer cell function in patients with acute leukemia
- 12 April 2025
- Published by Elsevier in International Immunopharmacology
- Vol. 154, 114566
Dysregulated glutathione metabolism impairs natural killer cell function in patients with acute leukemia
- 23 December 2024
- Published by Springer Nature in Nature Biomedical Engineering
- Vol. 9 (5) , 754-771
Enhanced engraftment of human haematopoietic stem cells via mechanical remodelling mediated by the corticotropin-releasing hormone
The engraftment of haematopoietic stem and progenitor cells (HSPCs), particularly in cord-blood transplants, remains challenging. Here we report the role of the corticotropin-releasing hormone (CRH) in enhancing the homing and engraftment of human-cord-blood HSPCs in bone marrow through mechanical remodelling. By using microfluidics, intravital two-photon imaging and long-term-engraftment assays, we show that treatment with CRH substantially enhances HSPC adhesion, motility and mechanical remodelling, ultimately leading to improved bone-marrow homing and engraftment in immunodeficient mice. CRH induces Ras homologue gene family member A (RhoA)-dependent nuclear translocation of the yes-associated protein (YAP), which upregulates the expression of genes encoding extracellular-matrix proteins (notably, thrombospondin-2 (THBS2)). This process guides the mechanical remodelling of HSPCs via modulation of the actin cytoskeleton and the extracellular matrix, with THBS2 interacting with the integrin αvβ3 and coordinating the nuclear translocation of YAP upon CRH/CRH-receptor-1 (CRH/CRHR1) signalling. Overall, the CRH/CRHR1/RhoA/YAP/THBS2/αvβ3 axis has a central role in modulating HSPC behaviour via a mechanical feedback loop involving THBS2, αvβ3, the actin cytoskeleton and YAP signalling. Our findings may suggest avenues for optimizing the transplantation of HSPCs.
- 23 December 2024
- Published by Springer Nature in Nature Biomedical Engineering
- Vol. 9 (5) , 754-771
Enhanced engraftment of human haematopoietic stem cells via mechanical remodelling mediated by the corticotropin-releasing hormone
The engraftment of haematopoietic stem and progenitor cells (HSPCs), particularly in cord-blood transplants, remains challenging. Here we report the role of the corticotropin-releasing hormone (CRH) in enhancing the homing and engraftment of human-cord-blood HSPCs in bone marrow through mechanical remodelling. By using microfluidics, intravital two-photon imaging and long-term-engraftment assays, we show that treatment with CRH substantially enhances HSPC adhesion, motility and mechanical remodelling, ultimately leading to improved bone-marrow homing and engraftment in immunodeficient mice. CRH induces Ras homologue gene family member A (RhoA)-dependent nuclear translocation of the yes-associated protein (YAP), which upregulates the expression of genes encoding extracellular-matrix proteins (notably, thrombospondin-2 (THBS2)). This process guides the mechanical remodelling of HSPCs via modulation of the actin cytoskeleton and the extracellular matrix, with THBS2 interacting with the integrin αvβ3 and coordinating the nuclear translocation of YAP upon CRH/CRH-receptor-1 (CRH/CRHR1) signalling. Overall, the CRH/CRHR1/RhoA/YAP/THBS2/αvβ3 axis has a central role in modulating HSPC behaviour via a mechanical feedback loop involving THBS2, αvβ3, the actin cytoskeleton and YAP signalling. Our findings may suggest avenues for optimizing the transplantation of HSPCs.
- Open Access
- 16 October 2024
- Published by Elsevier in STAR Protocols
- Vol. 5 (4) , 103387
Protocol to measure cell avidity between cord blood-derived NK cells and leukemia cell line KG-1a
- 16 October 2024
- Published by Elsevier in STAR Protocols
- Vol. 5 (4) , 103387
Open AccessProtocol to measure cell avidity between cord blood-derived NK cells and leukemia cell line KG-1a
- Open Access
- 21 May 2024
- Published by Elsevier in Cell Reports Medicine
- Vol. 5 (6) , 101580
Venetoclax acts as an immunometabolic modulator to potentiate adoptive NK cell immunotherapy against leukemia
- 21 May 2024
- Published by Elsevier in Cell Reports Medicine
- Vol. 5 (6) , 101580
Open AccessVenetoclax acts as an immunometabolic modulator to potentiate adoptive NK cell immunotherapy against leukemia
- Open Access
- 3 March 2023
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 14, 1136652
Unique metabolism and protein expression signature in human decidual NK cells
Human decidual natural killer (dNK) cells are a unique type of tissue-resident NK cells at the maternal-fetal interface. dNK cells are likely to have pivotal roles during pregnancy, including in maternal-fetal immune tolerance, trophoblast invasion, and fetal development. However, detailed insights into these cells are still lacking. In this study, we performed metabolomic and proteomic analyses on human NK cells derived from decidua and peripheral blood. We found that 77 metabolites were significantly changed in dNK cells. Notably, compared to peripheral blood NK (pNK) cells, 29 metabolites involved in glycerophospholipid and glutathione metabolism were significantly decreased in dNK cells. Moreover, we found that 394 proteins were differentially expressed in dNK cells. Pathway analyses and network enrichment analyses identified 110 differentially expressed proteins involved in focal adhesion, cytoskeleton remodeling, oxidoreductase activity, and fatty acid metabolism in dNK cells. The integrated proteomic and metabolomic analyses revealed significant downregulation in glutathione metabolism in dNK cells compared to pNK cells. Our data indicate that human dNK cells have unique metabolism and protein-expression features, likely regulating their function in pregnancy and immunity.
- 3 March 2023
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 14, 1136652
Open AccessUnique metabolism and protein expression signature in human decidual NK cells
Human decidual natural killer (dNK) cells are a unique type of tissue-resident NK cells at the maternal-fetal interface. dNK cells are likely to have pivotal roles during pregnancy, including in maternal-fetal immune tolerance, trophoblast invasion, and fetal development. However, detailed insights into these cells are still lacking. In this study, we performed metabolomic and proteomic analyses on human NK cells derived from decidua and peripheral blood. We found that 77 metabolites were significantly changed in dNK cells. Notably, compared to peripheral blood NK (pNK) cells, 29 metabolites involved in glycerophospholipid and glutathione metabolism were significantly decreased in dNK cells. Moreover, we found that 394 proteins were differentially expressed in dNK cells. Pathway analyses and network enrichment analyses identified 110 differentially expressed proteins involved in focal adhesion, cytoskeleton remodeling, oxidoreductase activity, and fatty acid metabolism in dNK cells. The integrated proteomic and metabolomic analyses revealed significant downregulation in glutathione metabolism in dNK cells compared to pNK cells. Our data indicate that human dNK cells have unique metabolism and protein-expression features, likely regulating their function in pregnancy and immunity.